Drug
Tarcocimab Tedromer
Tarcocimab Tedromer: highest development phase Phase 3, developed by Kodiak Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kodiak Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tarcocimab tedromer NCT06556368 | Phase 3 | Wet Age-related Macular Degeneration |
Latest
No recent events.
Follow Tarcocimab Tedromer on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.